SCI SCIENTIFIC COMMUNICATIONS & INFORMATION
DEAD

Serial Number

87255028

Owner

WPP PROPERTIES

Attorney

Jeffrey C. Katz

Filing Date

Dec 2, 2016

Add to watchlist:

No watchlists yet
View on USPTO

SCI SCIENTIFIC COMMUNICATIONS & INFORMATION Trademark

Serial Number: 87255028 • Registration: 5333250

SCI SCIENTIFIC COMMUNICATIONS & INFORMATION is a trademark filed by WPP PROPERTIES on December 2, 2016. The trademark is classified under Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

WPP PROPERTIES (552 trademarks)

100 PARK AVENUE
NEW YORK, NY 10017

Entity Type: 02

Trademark Details

Filing Date

December 2, 2016

Registration Date

November 14, 2017

Published for Opposition

August 29, 2017

Cancellation Date

May 28, 2024

Goods & Services

Consulting services relating to the publication of newsletters, manuscripts, articles, posters, abstracts, reports, white papers, tip sheets, books, ebooks and podium presentations in the field of medical education and research

Business marketing consulting services in the field of pharmaceuticals, biotechnology, clinical trials and medical affairs; providing market research and market data analytics in the field of pharmaceuticals, biotechnology, disease awareness, clinical trials and medical affairs; lobbying services, namely, promoting the interests of pharmaceutical and biotechnology enterprises in the fields of legislation and medical affairs; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting and management in the field of clinical trials, namely, providing information management services; recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; providing independent review of clinical trials for business purposes

Filing History

CANCELLED SEC. 8 (6-YR)
May 28, 2024 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 14, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 14, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 29, 2017 NPUB
PUBLISHED FOR OPPOSITION
Aug 29, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 9, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 17, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 29, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 28, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 28, 2016 GNRN
NON-FINAL ACTION E-MAILED
Dec 28, 2016 GNRT
NON-FINAL ACTION WRITTEN
Dec 28, 2016 CNRT
ASSIGNED TO EXAMINER
Dec 20, 2016 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Dec 8, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2016 NWOS
NEW APPLICATION ENTERED
Dec 6, 2016 NWAP